8-K Announcements
6Material company update
May 5, 2026·SEC
Material company update
Feb 19, 2026·SEC
Material company update
Jan 12, 2026·SEC
GRAIL, Inc.(GRAL)Earnings, Financials & Key Ratios
GRAL•NASDAQ
Price updated Jun 19, 2026
AboutGRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.Show more
- Revenue$147M+17.2%
- EBITDA-$378M+81.4%
- Net Income-$408M+79.9%
- EPS (Diluted)-11.11+82.5%
- Gross Margin-42.52%+31.6%
- EBITDA Margin-256.72%+84.1%
- Operating Margin-362.95%+79.2%
- Net Margin-277.47%+82.8%
- ROE-16.07%+75.6%
GRAL Key Insights
GRAIL, Inc. (GRAL) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Trading at only 0.9x book value
✗Weaknesses
- ✗Negative free cash flow
- ✗Shares diluted 15.2% in last year
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when GRAL posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
GRAL Price & Volume
GRAIL, Inc. (GRAL) stock price & volume — 10-year historical chart
Loading chart...
GRAL Growth Metrics
GRAIL, Inc. (GRAL) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years38.37%
TTM19.44%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM79.35%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM83%
Return on Capital
10 Years-43.45%
5 Years-41.2%
3 Years-36.43%
Last Year-18.58%
GRAL Recent Earnings
GRAIL, Inc. (GRAL) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 6/12 qtrs (86%)●Beat Revenue 5/12 qtrs (71%)
Q2 2026Latest
May 5, 2026Metric
Actual
Est
EPS
$2.29+17.1%
$2.76
Rev
$41M+4.2%
$39M
Q1 2026
Feb 19, 2026Metric
Actual
Est
EPS
$2.44+26.7%
$3.33
Rev
$44M+0.0%
$44M
Q4 2025
Nov 12, 2025Metric
Actual
Est
EPS
$2.46+26.8%
$3.36
Rev
$36M+4.6%
$35M
Q3 2025
Aug 12, 2025Metric
Actual
Est
EPS
$3.18-1.3%
$3.14
Rev
$36M+4.2%
$34M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 5, 2026 | $2.29vs $2.76+17.1% | $41Mvs $39M+4.2% |
| Q1 2026 | Feb 19, 2026 | $2.44vs $3.33+26.7% | $44Mvs $44M+0.0% |
| Q4 2025 | Nov 12, 2025 | $2.46vs $3.36+26.8% | $36Mvs $35M+4.6% |
| Q3 2025 | Aug 12, 2025 | $3.18vs $3.14-1.3% | $36Mvs $34M+4.2% |
Based on last 12 quarters of dataView full earnings history →
GRAL Peer Comparison
GRAIL, Inc. (GRAL) competitors in Molecular and Genetic Diagnostics — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 EXAS | 20.02B | 104.91 | -95.37 | 17.69% | -6.4% | -8.66% | 1.05 | |
 ILMN | 24.6B | 161.93 | 29.71 | -0.78% | 19.43% | 32.84% | 0.94 | |
 GH | 17.47B | 131.78 | -39.69 | 32.88% | -40.1% | |||
 NTRA | 33.14B | 231.41 | -152.24 | 35.9% | -9.05% | -15.13% | 0.13 | |
 FDMT | 504.97M | 9.66 | -3.99 | 2301.95% | -182.34% | -36.83% | 0.04 | |
 ACMR | 7.28B | 109.87 | 80.20 | 15.24% | 9.48% | 5.13% | 0.16 | |
 CDNA | 1.35B | 26.18 | -65.45 | 13.79% | -1.98% | -2.61% | 0.06 | |
 PACB | 434.84M | 1.40 | -0.77 | 3.89% | -80.34% | -488.45% | 141.98 |
Compare GRAL vs Peers
GRAIL, Inc. (GRAL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
GRAL Income Statement
GRAIL, Inc. (GRAL) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 0 | 0 | 0 | 14.61M | 55.55M | 93.11M | 125.59M | 147.17M | 156.12M |
Revenue Growth % | - | - | - | - | 280.17% | 67.61% | 34.9% | 17.18% | 19.44% |
Cost of Goods Sold | 0 | 0 | 0 | 114.61M | 172M | 188.72M | 203.62M | 209.75M | 179.22M |
COGS % of Revenue | - | - | - | 784.39% | 309.63% | 202.69% | 162.12% | 142.52% | - |
Gross Profit | 0▲ 0% | 0▲ 0% | 0▲ 0% | -100M▲ 0% | -116.45M▼ 16.4% | -95.61M▲ 17.9% | -78.02M▲ 18.4% | -62.57M▲ 19.8% | -23.1M▲ 0% |
Gross Margin % | - | - | - | -684.39% | -209.63% | -102.69% | -62.12% | -42.52% | -14.8% |
Gross Profit Growth % | - | - | - | - | -16.44% | 17.89% | 18.4% | 19.8% | - |
Operating Expenses | 287.5M | 255.66M | 316.42M | 1.17B | 5.33B | 1.42B | 2.11B | 471.59M | 521.22M |
OpEx % of Revenue | - | - | - | 7975.22% | 9588.56% | 1524.91% | 1680.91% | 320.43% | - |
Selling, General & Admin | 64.34M | 88.58M | 123.51M | 234.06M | 296.44M | 362.56M | 367.82M | 275.8M | 269.18M |
SG&A % of Revenue | - | - | - | 1601.81% | 533.64% | 389.41% | 292.86% | 187.4% | - |
Research & Development | 223.16M | 167.09M | 192.91M | 460.21M | 329.58M | 338.75M | 322.38M | 195.79M | 190.19M |
R&D % of Revenue | - | - | - | 3149.55% | 593.3% | 363.83% | 256.68% | 133.04% | - |
Other Operating Expenses | 0 | 0 | 0 | 471.07M | 4.7B | 718.47M | 1.42B | 0 | 2M |
Operating Income | -287.5M▲ 0% | -255.66M▲ 11.1% | -316.42M▼ 23.8% | -1.27B▼ 299.9% | -5.44B▼ 330.2% | -1.52B▲ 72.2% | -2.19B▼ 44.5% | -534.16M▲ 75.6% | -544.32M▲ 0% |
Operating Margin % | - | - | - | -8659.61% | -9798.18% | -1627.61% | -1743.03% | -362.95% | -348.66% |
Operating Income Growth % | - | 11.07% | -23.76% | -299.9% | -330.15% | 72.16% | -44.46% | 75.6% | - |
EBITDA | -273.42M | -245.36M | -308.85M | -1.21B | -5.29B | -1.36B | -2.03B | -377.82M | -388.46M |
EBITDA Margin % | - | - | - | -8259.6% | -9519.58% | -1457.16% | -1617.18% | -256.72% | -248.82% |
EBITDA Growth % | - | 10.26% | -25.88% | -290.77% | -338.16% | 74.34% | -49.71% | 81.4% | 80.16% |
D&A (Non-Cash Add-back) | 14.08M | 10.31M | 7.56M | 58.45M | 154.76M | 158.7M | 158.06M | 156.34M | 155.86M |
EBIT | -283.5M | -253.44M | -316.3M | -1.27B | -742.46M | -796.92M | -768.22M | -534.16M | -516.32M |
Net Interest Income | 8.34M | 12.43M | 6.14M | 332K | 1.74M | 7.95M | 26.73M | 28.65M | 28.86M |
Interest Income | 8.34M | 12.43M | 6.14M | 332K | 1.74M | 7.95M | 26.73M | 28.65M | 28.86M |
Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Income/Expense | 12.26M | 10.61M | 4.29M | 90K | 1.5M | 7.75M | 26.8M | -341K | 28.71M |
Pretax Income | -275.23M▲ 0% | -245.05M▲ 11.0% | -312.12M▼ 27.4% | -1.27B▼ 305.4% | -5.44B▼ 330.1% | -1.51B▲ 72.3% | -2.16B▼ 43.4% | -534.5M▲ 75.3% | -515.62M▲ 0% |
Pretax Margin % | - | - | - | -8658.99% | -9795.48% | -1619.29% | -1721.69% | -363.18% | -330.27% |
Income Tax | 485K | -195K | 33K | -17.48M | -42.29M | -41.95M | -135.36M | -126.15M | -120.29M |
Effective Tax Rate % | -0.18% | 0.08% | -0.01% | 1.38% | 0.78% | 2.78% | 6.26% | 23.6% | 23.33% |
Net Income | -275.72M▲ 0% | -244.85M▲ 11.2% | -312.16M▼ 27.5% | -1.25B▼ 299.7% | -5.4B▼ 332.7% | -1.47B▲ 72.9% | -2.03B▼ 38.3% | -408.35M▲ 79.9% | -395.32M▲ 0% |
Net Margin % | - | - | - | -8539.39% | -9719.35% | -1574.23% | -1613.92% | -277.47% | -253.22% |
Net Income Growth % | - | 11.19% | -27.49% | -299.73% | -332.7% | 72.85% | -38.3% | 79.85% | 79.35% |
Net Income (Continuing) | -275.72M | -244.85M | -312.16M | -1.25B | -5.4B | -1.47B | -2.03B | -408.35M | -395.32M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -2.42▲ 0% | -1.99▲ 17.8% | -2.52▼ 26.6% | -40.18▼ 1494.4% | -173.87▼ 332.7% | -47.20▲ 72.9% | -63.54▼ 34.6% | -11.11▲ 82.5% | -9.73▲ 0% |
EPS Growth % | - | 17.77% | -26.63% | -1494.44% | -332.73% | 72.85% | -34.62% | 82.52% | 83% |
EPS (Basic) | -2.42 | -1.99 | -2.52 | -40.18 | -173.87 | -47.20 | -63.54 | -11.11 | - |
Diluted Shares Outstanding | 114.14M | 123.19M | 123.67M | 31.05M | 31.05M | 31.05M | 31.9M | 36.75M | 40.64M |
Basic Shares Outstanding | 114.14M | 123.19M | 123.67M | 31.05M | 31.05M | 31.05M | 31.9M | 36.75M | 40.64M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
GRAL Balance Sheet
GRAIL, Inc. (GRAL) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 649.23M | 557.51M | 595.92M | 242.73M | 295.63M | 156.06M | 819.86M | 953.85M | 877.35M |
Cash & Short-Term Investments | 641.35M | 544.34M | 583.48M | 221.16M | 241.6M | 97.29M | 763.47M | 904.43M | 823.11M |
Cash Only | 95.09M | 143.19M | 170.19M | 221.16M | 241.6M | 97.29M | 214.23M | 249.73M | 69.34M |
Short-Term Investments | 546.26M | 401.15M | 413.29M | 0 | 0 | 0 | 549.24M | 654.7M | 753.76M |
Accounts Receivable | 0 | 0 | 0 | 6.88M | 18.61M | 22.35M | 24.64M | 18.3M | 20.34M |
Days Sales Outstanding | - | - | - | 171.91 | 122.31 | 87.63 | 71.61 | 45.37 | 41.71 |
Inventory | 0 | 0 | 0 | 0 | 19.75M | 21.7M | 18.63M | 16.02M | 0 |
Days Inventory Outstanding | - | - | - | - | 41.92 | 41.96 | 33.4 | 27.87 | 19.41 |
Other Current Assets | 0 | 0 | 0 | 6.89M | 0 | 0 | 0 | 15.11M | 33.9M |
Total Non-Current Assets | 37.61M | 78.01M | 110.38M | 9.5B | 5.31B | 4.4B | 2.16B | 1.97B | 1.93B |
Property, Plant & Equipment | 33.04M | 59.46M | 101.39M | 216.37M | 198.72M | 169.38M | 135.43M | 103.88M | 95.91M |
Fixed Asset Turnover | - | - | - | 0.07x | 0.28x | 0.55x | 0.93x | 1.42x | 1.44x |
Goodwill | 0 | 0 | 0 | 6.2B | 1.5B | 888.94M | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 3.07B | 2.94B | 2.69B | 2.02B | 1.85B | 1.82B |
Long-Term Investments | 1.63M | 15.16M | 2.05M | 0 | 4.53M | 4.22M | 0 | 6.97M | 0 |
Other Non-Current Assets | 2.94M | 3.38M | 6.94M | 7.1M | 6.14M | 7.98M | 11.12M | 6.75M | 14.25M |
Total Assets | 686.85M▲ 0% | 635.52M▼ 7.5% | 706.3M▲ 11.1% | 9.74B▲ 1278.7% | 5.6B▼ 42.5% | 4.56B▼ 18.7% | 2.98B▼ 34.5% | 2.92B▼ 2.1% | 2.8B▲ 0% |
Asset Turnover | - | - | - | 0.00x | 0.01x | 0.02x | 0.04x | 0.05x | 0.06x |
Asset Growth % | - | -7.47% | 11.14% | 1278.73% | -42.47% | -18.66% | -34.53% | -2.05% | -37.53% |
Total Current Liabilities | 74.16M | 44.93M | 83.97M | 97.89M | 134.94M | 163.61M | 76.92M | 79.67M | 74.71M |
Accounts Payable | 12.75M | 6.09M | 24.51M | 17.65M | 17.48M | 19.67M | 4.84M | 2.08M | 4.67M |
Days Payables Outstanding | - | - | - | 56.2 | 37.1 | 38.05 | 8.68 | 3.62 | 8.37 |
Short-Term Debt | 0 | 0 | 0 | 0 | 13.34M | 14.81M | 0 | 11.71M | 9.94M |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 1.6M | 0 | 0 |
Other Current Liabilities | 267K | 23K | 12.41M | 4.51M | 65.96M | 87.64M | 22.69M | 65.87M | 60.1M |
Current Ratio | 8.75x | 12.41x | 7.10x | 2.48x | 2.19x | 0.95x | 10.66x | 11.97x | 11.74x |
Quick Ratio | 8.75x | 12.41x | 7.10x | 2.48x | 2.04x | 0.82x | 10.42x | 11.77x | 11.74x |
Cash Conversion Cycle | - | - | - | - | 127.14 | 91.54 | 96.33 | 69.62 | 52.76 |
Total Non-Current Liabilities | 12.32M | 40.06M | 60.49M | 209.51M | 821M | 747.13M | 402.98M | 264.48M | 228.08M |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 43.15M | 41.09M |
Capital Lease Obligations | 800K | 36.64M | 57.54M | 96.75M | 82.67M | 69.6M | 54.88M | 43.15M | 136.19M |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 735.19M | 676.03M | 345.86M | 218.58M | 905.06M |
Other Non-Current Liabilities | 11.52M | 3.42M | 2.95M | 112.76M | 3.13M | 1.5M | 2.24M | -40.4M | 2.95M |
Total Liabilities | 86.47M | 84.99M | 144.46M | 307.4M | 955.94M | 910.74M | 479.9M | 344.15M | 302.79M |
Total Debt | 2.52M | 42.04M | 62.99M | 110.56M | 96.01M | 84.41M | 68.14M | 98.01M | 51.03M |
Net Debt | -92.57M | -101.15M | -107.21M | -110.6M | -145.59M | -12.88M | -146.09M | -151.72M | -18.31M |
Debt / Equity | 0.00x | 0.08x | 0.11x | 0.01x | 0.02x | 0.02x | 0.03x | 0.04x | 0.02x |
Debt / EBITDA | - | - | - | - | - | - | - | - | -0.13x |
Net Debt / EBITDA | - | - | - | - | - | - | - | - | 0.05x |
Interest Coverage | - | - | - | - | - | - | - | - | - |
Total Equity | 600.37M▲ 0% | 550.53M▼ 8.3% | 561.84M▲ 2.1% | 9.43B▲ 1578.5% | 4.65B▼ 50.7% | 3.65B▼ 21.5% | 2.5B▼ 31.3% | 2.58B▲ 3.0% | 2.5B▲ 0% |
Equity Growth % | - | -8.3% | 2.05% | 1578.52% | -50.73% | -21.52% | -31.34% | 2.97% | -20.97% |
Book Value per Share | 5.26 | 4.47 | 4.54 | 303.69 | 149.62 | 117.42 | 78.47 | 70.14 | 61.53 |
Total Shareholders' Equity | 600.37M | 550.53M | 561.84M | 9.43B | 4.65B | 3.65B | 2.5B | 2.58B | 2.5B |
Common Stock | 129K | 138K | 151K | 10.34B | 10.96B | 11.42B | 34K | 40K | 41K |
Retained Earnings | -1.06B | -1.31B | -1.62B | -911.54M | -6.31B | -7.78B | -9.8B | -10.21B | -10.3B |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | 128K | 2.46M | 3.6M | 315K | 894K | 1.07M | 1.45M | 2.65M | 1.87M |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GRAL Cash Flow Statement
GRAIL, Inc. (GRAL) cash flow — operating, investing & free cash flow history
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -209.26M | -245.79M | -232M | -688.13M | -561.31M | -595.8M | -577.16M | -299.01M | -290.98M |
Operating CF Margin % | - | - | - | -4709.35% | -1010.46% | -639.92% | -459.54% | -203.17% | - |
Operating CF Growth % | - | -17.46% | 5.61% | -196.61% | 18.43% | -6.14% | 3.13% | 48.19% | 134.94% |
Net Income | -275.72M | -244.85M | -312.16M | -1.25B | -5.4B | -1.47B | -2.03B | -408.35M | -395.32M |
Depreciation & Amortization | 14.08M | 10.31M | 7.56M | 58.45M | 154.76M | 158.7M | 158.06M | 0 | -485K |
Stock-Based Compensation | 11.04M | 28.39M | 45.99M | 681.91M | 75.73M | 97.23M | 86.08M | 0 | 582K |
Deferred Taxes | 0 | 0 | 0 | 0 | -39.06M | -38.15M | -134.25M | 0 | 5.65M |
Other Non-Cash Items | 1.66M | -353K | 9.38M | -201M | 4.66B | 644.38M | 1.36B | 96.94M | 100.12M |
Working Capital Changes | 39.67M | -39.28M | 17.22M | 20.29M | -14.46M | 7.72M | -24.28M | 12.41M | -1.53M |
Change in Receivables | 0 | 0 | 0 | -6.88M | -8.68M | -1.38M | -3.37M | 1.69M | -3.03M |
Change in Inventory | 0 | 0 | 0 | -5.67M | -14.08M | -1.94M | 3.07M | 2.62M | 34K |
Change in Payables | -338K | -6.55M | 0 | 0 | 2.34M | 2.89M | -14.63M | -2.73M | 1.74M |
Cash from Investing | -93.39M | 133.04M | -12.79M | 344.81M | -22.86M | -12.89M | -551.01M | -85.05M | -193.1M |
Capital Expenditures | -15.99M | -3.33M | -11.9M | -69.93M | -22.86M | -12.89M | -5.21M | -909K | -441K |
CapEx % of Revenue | - | - | - | 478.55% | 41.15% | 13.84% | 4.15% | 0.62% | 0.28% |
Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - |
Other Investing | -77.4M | 136.37M | -885K | 414.74M | 0 | 0 | 0 | 0 | -85.05M |
Cash from Financing | 300.62M | 160.33M | 275.11M | 394.74M | 604.82M | 463.77M | 1.24B | 423.32M | 423.32M |
Debt Issued (Net) | -1.51M | -1.56M | -812K | 0 | 0 | 0 | 0 | 0 | 0 |
Equity Issued (Net) | 0 | 0 | 0 | 5.81M | 0 | 0 | 0 | 423.32M | 0 |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | -170K | 0 | 0 | 0 | 0 | 0 |
Other Financing | 302.13M | 161.88M | 275.92M | 388.93M | 604.82M | 463.77M | 1.24B | 0 | 423.32M |
Net Change in Cash | -1.55M▲ 0% | 47.69M▲ 3179.0% | 30.35M▼ 36.4% | -143.19M▼ 571.8% | 20.13M▲ 114.1% | -144.62M▼ 818.3% | 116.07M▲ 180.3% | 39.12M▼ 66.3% | -60.93M▲ 0% |
Free Cash Flow | -225.25M▲ 0% | -249.13M▼ 10.6% | -243.91M▲ 2.1% | -758.06M▼ 210.8% | -584.17M▲ 22.9% | -608.69M▼ 4.2% | -582.36M▲ 4.3% | -299.01M▲ 48.7% | -291.43M▲ 0% |
FCF Margin % | - | - | - | -5187.9% | -1051.61% | -653.76% | -463.68% | -203.17% | -186.67% |
FCF Growth % | - | -10.6% | 2.09% | -210.8% | 22.94% | -4.2% | 4.32% | 48.66% | 37.68% |
FCF per Share | -1.97 | -2.02 | -1.97 | -24.41 | -18.81 | -19.60 | -18.26 | -8.14 | -7.17 |
FCF Conversion (FCF/Net Income) | 0.76x | 1.00x | 0.74x | 0.55x | 0.10x | 0.41x | 0.28x | 0.73x | 0.74x |
Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GRAL Key Ratios
GRAIL, Inc. (GRAL) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -42.55% | -56.12% | -24.97% | -76.71% | -35.35% | -65.92% | -16.07% | -16.42% |
Return on Invested Capital (ROIC) | -40.06% | -52.5% | -19.42% | -59.07% | -27.95% | -54.81% | -16.75% | -17.5% |
Gross Margin | - | - | -684.39% | -209.63% | -102.69% | -62.12% | -42.52% | -14.8% |
Net Margin | - | - | -8539.39% | -9719.35% | -1574.23% | -1613.92% | -277.47% | -253.22% |
Debt / Equity | 0.08x | 0.11x | 0.01x | 0.02x | 0.02x | 0.03x | 0.04x | 0.02x |
FCF Conversion | 1.00x | 0.74x | 0.55x | 0.10x | 0.41x | 0.28x | 0.73x | 0.74x |
Revenue Growth | - | - | - | 280.17% | 67.61% | 34.9% | 17.18% | 19.44% |
Related:GRAL Dividend History·GRAL Revenue History·GRAL Price History·GRAL P/E History·GRAL Financial Ratios·GRAL Institutional Holders
GRAL SEC Filings & Documents
GRAIL, Inc. (GRAL) SEC filings — annual & quarterly reports (10-K, 10-Q)
GRAL Frequently Asked Questions
GRAIL, Inc. (GRAL) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
GRAIL, Inc. (GRAL) reported $156.1M in revenue for fiscal year 2025.
GRAIL, Inc. (GRAL) grew revenue by 17.2% over the past year. This is strong growth.
GRAIL, Inc. (GRAL) reported a net loss of $395.3M for fiscal year 2025.
Dividend & Returns
GRAIL, Inc. (GRAL) has a return on equity (ROE) of -16.1%. Negative ROE indicates the company is unprofitable.
GRAIL, Inc. (GRAL) had negative free cash flow of $291.4M in fiscal year 2025, likely due to heavy capital investments.